Celgene Corp. (NASDAQ:CELG) broke from a cup-and-handle followed by a breakaway gap. More
-
-
Sponsored By:
-
Sponsored By:
CELG
Stocks Dip on Pre-Earnings Jitters — Tuesday’s IP Market Recap
Investors leery of a potentially weak fourth-quarter earnings season bid stocks down lower Tuesday, though Alcoa "officially" started things off right after the bell. More
Strong Sectors to Watch
Homebuilders, cell tower providers and biotech look strong; find out the specific names I'm watching. More
4 Biotechnology Stocks to Buy Now
The grades of four Biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Must-Own Biotech $1 Away From Buy Price
Celgene Corp. (NASDAQ:CELG) is in a powerful bull trend and should be bought on a pullback. More
Finally, IPOs Come Back From Vacation
The IPO market is emerging from its late-summer hibernation, with seven deals on tap for this week. Here's a look at three that stand out. More
8 Biotechnology Stocks to Buy Now
This week, 8 Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
